- Home
- EVGOW vs LIMNW Comparison
EVGOW vs LIMNW Comparison
Compare EVGOW & LIMNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- LIMNW
- Stock Information
- Founded
- EVGOW 2010
- LIMNW N/A
- Country
- EVGOW United States
- LIMNW United States
- Employees
- EVGOW 331
- LIMNW N/A
- Industry
- EVGOW Other Specialty Stores
- LIMNW
- Sector
- EVGOW Consumer Discretionary
- LIMNW
- Exchange
- EVGOW Nasdaq
- LIMNW Nasdaq
- Market Cap
- EVGOW N/A
- LIMNW N/A
- IPO Year
- EVGOW N/A
- LIMNW N/A
- Fundamental
- Price
- EVGOW $0.20
- LIMNW $0.32
- Analyst Decision
- EVGOW
- LIMNW
- Analyst Count
- EVGOW 0
- LIMNW 0
- Target Price
- EVGOW N/A
- LIMNW N/A
- AVG Volume (30 Days)
- EVGOW 74.7K
- LIMNW N/A
- Earning Date
- EVGOW 03-07-2025
- LIMNW N/A
- Dividend Yield
- EVGOW N/A
- LIMNW N/A
- EPS Growth
- EVGOW N/A
- LIMNW N/A
- EPS
- EVGOW N/A
- LIMNW N/A
- Revenue
- EVGOW $239,306,000.00
- LIMNW N/A
- Revenue This Year
- EVGOW N/A
- LIMNW N/A
- Revenue Next Year
- EVGOW N/A
- LIMNW N/A
- P/E Ratio
- EVGOW N/A
- LIMNW N/A
- Revenue Growth
- EVGOW 73.08
- LIMNW N/A
- 52 Week Low
- EVGOW $0.12
- LIMNW N/A
- 52 Week High
- EVGOW $1.99
- LIMNW N/A
- Technical
- Relative Strength Index (RSI)
- EVGOW 43.84
- LIMNW N/A
- Support Level
- EVGOW $0.19
- LIMNW N/A
- Resistance Level
- EVGOW $0.24
- LIMNW N/A
- Average True Range (ATR)
- EVGOW 0.01
- LIMNW 0.00
- MACD
- EVGOW 0.00
- LIMNW 0.00
- Stochastic Oscillator
- EVGOW 25.29
- LIMNW 0.00
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About LIMNW Liminatus Pharma Inc. Warrants
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.